Literature DB >> 7295459

The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.

J L Reid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295459      PMCID: PMC1401811          DOI: 10.1111/j.1365-2125.1981.tb01217.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  35 in total

1.  Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties.

Authors:  A L Muir; J L Burton; D M Lawrie
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

2.  Intravenous clonidine in hypertensive patients.

Authors:  W J Mroczek; M Davidov; F A Finnerty
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

3.  Observations on the hypotensive action of "Catapres" (ST 155) in man.

Authors:  A J Barnett; S Cantor
Journal:  Med J Aust       Date:  1968-01-20       Impact factor: 7.738

4.  Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

5.  Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.

Authors:  M Henning
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1969

6.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

7.  The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients.

Authors:  B Hökfelt; H Hedeland; B G Hansson
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-02

8.  [Critical considerations on the method of action of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride].

Authors:  W Graubner; M Wolf
Journal:  Arzneimittelforschung       Date:  1966-08

9.  Effects of clonidine withdrawal: possible mechanisms and suggestions for management.

Authors:  S N Hunyor; L Hansson; T S Harrison; S W Hoobler
Journal:  Br Med J       Date:  1973-04-28

10.  Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline.

Authors:  C Zamboulis; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

View more
  12 in total

1.  The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome.

Authors:  L Gregorakos; T Thomaides; S Stratouli; E Sakayanni
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

2.  Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.

Authors:  R H Hou; E R Samuels; M Raisi; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-11-25       Impact factor: 4.530

3.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  Oral clonidine reduces postoperative PCA morphine requirements.

Authors:  J Park; J Forrest; R Kolesar; D Bhola; S Beattie; C Chu
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

Review 5.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

6.  Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels.

Authors:  M A Phillips; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

7.  Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers.

Authors:  R H Hou; C Freeman; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

8.  Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.

Authors:  M Scheinin; A Kallio; M Koulu; J Viikari; H Scheinin
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 9.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

10.  Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.

Authors:  S Karhuvaara; A Kallio; M Scheinin; M Anttila; J S Salonen; H Scheinin
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.